Geis W P, Iwatsuki S, Molnar Z, Giacchino J L, Kerman R H, Ing T S, Hano J E
Arch Surg. 1978 Apr;113(4):461-6. doi: 10.1001/archsurg.1978.01370160119020.
Five renal transplant recipients exhibited giant systemic lymphadenopathy shortly after transplantation. Biopsy specimens did not show Hodgkin's lymphoma. Immunosuppression was continued in all patients. In contrast to the rapidly fatal course of malignant lymphoma in transplant recipients, adenopathy in these five patients has uniformly resolved. Patients have been observed for 6 to 15 months with no evidence of residual disease. Interval biopsy specimens are not malignant. Each patient received antithymocyte globulin from a single lot for 10 to 21 days after transplantation. During administration, T cell lymphocytes were suppressed to 5% of control values. When lymphadenopathy occurred, T cell values rebounded to 371% of control values. Toxoplasmosis titers as well as viral cultures of lymph node biopsy specimens were negative. These data indicate a benign course of this histologically malignant disease and suggest a lymphoblastic rebound phenomenon to antithymocyte globulin.
五名肾移植受者在移植后不久出现全身性巨大淋巴结病。活检标本未显示霍奇金淋巴瘤。所有患者均继续进行免疫抑制治疗。与移植受者中恶性淋巴瘤的快速致命病程不同,这五名患者的淋巴结病均已完全消退。对患者进行了6至15个月的观察,没有残留疾病的证据。间隔活检标本并非恶性。每名患者在移植后接受了来自同一批次的抗胸腺细胞球蛋白治疗10至21天。给药期间,T细胞淋巴细胞被抑制至对照值的5%。当出现淋巴结病时,T细胞值反弹至对照值的371%。弓形虫抗体滴度以及淋巴结活检标本的病毒培养均为阴性。这些数据表明这种组织学上为恶性的疾病病程呈良性,并提示对抗胸腺细胞球蛋白存在淋巴细胞反弹现象。